ANGIOTENSIN CONVERTING ENZYME INHIBITOR PRESCRIPTION IN SINGLE VENTRICLE PATIENTS ENROLLED IN THE NATIONAL PEDIATRIC CARDIOLOGY QUALITY IMPROVEMENT COLLABORATIVE REGISTRY

The Infants Single Ventricle trial published in 2010 demonstrated no benefit of angiotensin converting enzyme inhibitor (ACEi) over placebo. The effects of this study on prescribing patterns are unclear. We sought to describe ACEi prescription in the interstage between stage 1 palliation (S1P)